Tema Neuroscience and Mental Health ETF (NASDAQ:MNTL) Sees Significant Decline in Short Interest

Tema Neuroscience and Mental Health ETF (NASDAQ:MNTL) was the recipient of a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling 300 shares, a decline of 75.0% from the December 31st total of 1,200 shares. Based on an average daily volume of 400 shares, the short-interest ratio is presently 0.8 days.

Tema Neuroscience and Mental Health ETF Trading Up 0.2 %

NASDAQ MNTL traded up $0.06 during trading hours on Tuesday, reaching $25.67. The company’s stock had a trading volume of 200 shares, compared to its average volume of 106. The business has a 50-day simple moving average of $25.17 and a 200 day simple moving average of $26.16. Tema Neuroscience and Mental Health ETF has a 52 week low of $23.67 and a 52 week high of $27.66. The stock has a market cap of $11.30 million, a PE ratio of 25.24 and a beta of 0.99.

Tema Neuroscience and Mental Health ETF Announces Dividend

The business also recently declared a dividend, which was paid on Thursday, December 12th. Investors of record on Wednesday, December 11th were issued a $0.257 dividend. The ex-dividend date of this dividend was Wednesday, December 11th.

About Tema Neuroscience and Mental Health ETF

The Tema Neuroscience and Mental Health ETF (MNTL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, concentrating on companies engaged in addressing disorders of the central nervous system and mental health worldwide. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.